334 related articles for article (PubMed ID: 8151775)
1. Equine infectious anemia virus trans-regulatory protein Rev controls viral mRNA stability, accumulation, and alternative splicing.
Martarano L; Stephens R; Rice N; Derse D
J Virol; 1994 May; 68(5):3102-11. PubMed ID: 8151775
[TBL] [Abstract][Full Text] [Related]
2. cis-Acting and trans-acting modulation of equine infectious anemia virus alternative RNA splicing.
Liao HJ; Baker CC; Princler GL; Derse D
Virology; 2004 May; 323(1):131-40. PubMed ID: 15165825
[TBL] [Abstract][Full Text] [Related]
3. Binding of equine infectious anemia virus rev to an exon splicing enhancer mediates alternative splicing and nuclear export of viral mRNAs.
Belshan M; Park GS; Bilodeau P; Stoltzfus CM; Carpenter S
Mol Cell Biol; 2000 May; 20(10):3550-7. PubMed ID: 10779344
[TBL] [Abstract][Full Text] [Related]
4. Interactions among SR proteins, an exonic splicing enhancer, and a lentivirus Rev protein regulate alternative splicing.
Gontarek RR; Derse D
Mol Cell Biol; 1996 May; 16(5):2325-31. PubMed ID: 8628299
[TBL] [Abstract][Full Text] [Related]
5. Binding sites for Rev and ASF/SF2 map to a 55-nucleotide purine-rich exonic element in equine infectious anemia virus RNA.
Chung H ; Derse D
J Biol Chem; 2001 Jun; 276(22):18960-7. PubMed ID: 11278454
[TBL] [Abstract][Full Text] [Related]
6. Identification of a Novel Post-transcriptional Transactivator from the Equine Infectious Anemia Virus.
Li J; Zhang X; Bai B; Zhang M; Ma W; Lin Y; Wang X; Wang XF
J Virol; 2022 Dec; 96(24):e0121022. PubMed ID: 36448796
[TBL] [Abstract][Full Text] [Related]
7. Roles of viral and cellular proteins in the expression of alternatively spliced HTLV-1 pX mRNAs.
Princler GL; Julias JG; Hughes SH; Derse D
Virology; 2003 Dec; 317(1):136-45. PubMed ID: 14675632
[TBL] [Abstract][Full Text] [Related]
8. A Novel, Fully Spliced, Accessory Gene in Equine Lentivirus with Distinct Rev-Responsive Element.
Zhang X; Li J; Zhang M; Bai B; Ma W; Lin Y; Guo X; Wang XF; Wang X
J Virol; 2022 Sep; 96(18):e0098622. PubMed ID: 36069548
[TBL] [Abstract][Full Text] [Related]
9. Co-expression of a trans-dominant negative mutant of the human immunodeficiency virus type 1 (HIV-1) Rev protein affects the Rev-dependent splicing pattern and expression of HIV-1 RNAs.
Szilvay AM; Bøe SO; Kalland KH
J Gen Virol; 1999 Aug; 80 ( Pt 8)():1965-1974. PubMed ID: 10466792
[TBL] [Abstract][Full Text] [Related]
10. Synergistic stimulation of HIV-1 rev-dependent export of unspliced mRNA to the cytoplasm by hnRNP A1.
Najera I; Krieg M; Karn J
J Mol Biol; 1999 Feb; 285(5):1951-64. PubMed ID: 9925777
[TBL] [Abstract][Full Text] [Related]
11. Molecular and biological characterization of equine infectious anemia virus Rev.
Carpenter S; Dobbs D
Curr HIV Res; 2010 Jan; 8(1):87-93. PubMed ID: 20210784
[TBL] [Abstract][Full Text] [Related]
12. Proviral DNA integration and transcriptional patterns of equine infectious anemia virus during persistent and cytopathic infections.
Rasty S; Dhruva BR; Schiltz RL; Shih DS; Issel CJ; Montelaro RC
J Virol; 1990 Jan; 64(1):86-95. PubMed ID: 2152836
[TBL] [Abstract][Full Text] [Related]
13. Elements distinct from human immunodeficiency virus type 1 splice sites are responsible for the Rev dependence of env mRNA.
Nasioulas G; Zolotukhin AS; Tabernero C; Solomin L; Cunningham CP; Pavlakis GN; Felber BK
J Virol; 1994 May; 68(5):2986-93. PubMed ID: 8151769
[TBL] [Abstract][Full Text] [Related]
14. A role for Rev in the association of HIV-1 gag mRNA with cytoskeletal beta-actin and viral protein expression.
Kimura T; Hashimoto I; Nishikawa M; Fujisawa JI
Biochimie; 1996; 78(11-12):1075-80. PubMed ID: 9150887
[TBL] [Abstract][Full Text] [Related]
15. Biological characterization of Rev variation in equine infectious anemia virus.
Belshan M; Harris ME; Shoemaker AE; Hope TJ; Carpenter S
J Virol; 1998 May; 72(5):4421-6. PubMed ID: 9557734
[TBL] [Abstract][Full Text] [Related]
16. Structural and functional characterization of rev-like transcripts of equine infectious anemia virus.
Rosin-Arbesfeld R; Rivlin M; Noiman S; Mashiah P; Yaniv A; Miki T; Tronick SR; Gazit A
J Virol; 1993 Sep; 67(9):5640-6. PubMed ID: 8394464
[TBL] [Abstract][Full Text] [Related]
17. Cloning and characterization of cDNAs encoding equine infectious anemia virus tat and putative Rev proteins.
Stephens RM; Derse D; Rice NR
J Virol; 1990 Aug; 64(8):3716-25. PubMed ID: 2164593
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory activity of the equine infectious anemia virus major 5' splice site in the absence of Rev.
Tan W; Schalling M; Zhao C; Luukkonen M; Nilsson M; Fenyö EM; Pavlakis GN; Schwartz S
J Virol; 1996 Jun; 70(6):3645-58. PubMed ID: 8648699
[TBL] [Abstract][Full Text] [Related]
19. Distinct RNA sequences in the gag region of human immunodeficiency virus type 1 decrease RNA stability and inhibit expression in the absence of Rev protein.
Schwartz S; Felber BK; Pavlakis GN
J Virol; 1992 Jan; 66(1):150-9. PubMed ID: 1727477
[TBL] [Abstract][Full Text] [Related]
20. Characterization of functional domains of equine infectious anemia virus Rev suggests a bipartite RNA-binding domain.
Lee JH; Murphy SC; Belshan M; Sparks WO; Wannemuehler Y; Liu S; Hope TJ; Dobbs D; Carpenter S
J Virol; 2006 Apr; 80(8):3844-52. PubMed ID: 16571801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
